An innovator at heart, Jeff Geschwind, MD founded Cage Pharma. His research focuses on disrupting cancer's energy source by targeting tumor glycolysis. This work aims to develop powerful new metabolic drugs for oncology. https://www.linkedin.com/in/jeff-geschwind-037200174